Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)

CNY 13.35

(0.3%)

EBITDA Summary of Ningbo Menovo Pharmaceutical Co., Ltd.

  • Ningbo Menovo Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 155.45 Million CNY , down -60.3% from previous year.
  • Ningbo Menovo Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 57.18 Million CNY , up 89.21% from previous quarter.
  • Ningbo Menovo Pharmaceutical Co., Ltd. reported an annual EBITDA of 498.48 Million CNY in 2022, up 71.0% from previous year.
  • Ningbo Menovo Pharmaceutical Co., Ltd. reported an annual EBITDA of 301.57 Million CNY in 2021, down -15.15% from previous year.
  • Ningbo Menovo Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 20.78 Million CNY for 2024 Q1, up 658.48% from previous quarter.
  • Ningbo Menovo Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 22.46 Million CNY for 2024 Q2, down -44.42% from previous quarter.

Annual EBITDA Chart of Ningbo Menovo Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Ningbo Menovo Pharmaceutical Co., Ltd. (2023 - 2011)

Year EBITDA EBITDA Growth
2023 155.45 Million CNY -60.3%
2022 498.48 Million CNY 71.0%
2021 301.57 Million CNY -15.15%
2020 321.39 Million CNY 28.24%
2019 275.05 Million CNY 54.08%
2018 158.39 Million CNY 82.61%
2017 101.17 Million CNY -33.09%
2016 116.14 Million CNY 13.83%
2015 111.39 Million CNY 2.06%
2014 128.2 Million CNY 59.81%
2013 84.81 Million CNY -2.87%
2012 87.42 Million CNY 2.01%
2011 82.81 Million CNY 0.0%

Peer EBITDA Comparison of Ningbo Menovo Pharmaceutical Co., Ltd.

Name EBITDA EBITDA Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 95.703%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 60.32%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 97.593%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 84.825%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 92.047%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 86.319%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 84.004%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 271.219%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 96.59%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 4329.685%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 96.899%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -39.727%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 77.06%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 41.461%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 92.788%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 43.496%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 90.268%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 90.297%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 67.226%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 25.878%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 67.548%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 78.894%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 17.066%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 56.22%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 79.083%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 166.395%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 96.207%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 80.613%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 16.644%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 89.756%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 92.996%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 41.693%
China National Medicines Corporation Ltd. 2.82 Billion CNY 94.499%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 86.829%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 81.513%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY -27.67%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -42981.434%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 76.551%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -351.248%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -784.328%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 84.911%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 75.452%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 81.495%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 46.77%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 97.204%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 74.728%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 49.869%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 55.439%
Guobang Pharma Ltd. 1.04 Billion CNY 85.072%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -4712.998%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 71.037%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 85.819%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 52.536%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY -39.033%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 72.523%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 368.74%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 37.945%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 92.142%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 20.446%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 84.075%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 23.61%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 41.875%
CanSino Biologics Inc. -1.64 Billion CNY 109.44%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 40.183%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 79.047%